US approval for Israeli ECG system

The US FDA has approved the innovative ECG system HyperQ Analyzer Rest developed by Israeli biotech BSP.  HyperQ can test patients at rest, diagnosing early-stage heart disease without putting the patient under stress. It is less risky than alternative invasive and radioactivity tests.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *